News + Filings Transactions
|
Casdin Eli
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/14/2023 | STANDARD BIOTOOLS INC. | FLDM | Grant | Common Stock | 26.4k | $0.00 | $0 | | 06/14/2023 |
| 06/14/2023 | STANDARD BIOTOOLS INC. | FLDM | Grant | Stock Option (Right to Buy) | 35.4k | $2.18 | $77.1k | | 06/14/2023 |
| 05/19/2023 | STANDARD BIOTOOLS INC. | FLDM | Purchase | Common Stock | 800k | $2.29 | $1.8M | See footnote | 05/17/2023 |
| 05/18/2023 | STANDARD BIOTOOLS INC. | FLDM | Purchase | Common Stock | 150k | $2.16 | $323.9k | See footnote | 05/17/2023 |
| 05/17/2023 | STANDARD BIOTOOLS INC. | FLDM | Purchase | Common Stock | 250k | $1.89 | $471.6k | See footnote | 05/17/2023 |
| 03/17/2023 | SomaLogic, Inc. | | Grant | Common Stock | 3.4k | $0.00 | $0 | | 03/17/2023 |
| 03/17/2023 | SomaLogic, Inc. | | Grant | Employee Stock Option (right to buy) | 20.6k | $2.30 | $47.4k | | 03/17/2023 |
| 01/01/2023 | EQRx, Inc. | | Grant | Earn-out Shares | 18.2k | $0.00 | $0 | By Casdin Partners Master Fund L.P. | 01/01/2023 |
| 01/01/2023 | EQRx, Inc. | | Grant | Earn-out Shares | 2.8k | $0.00 | $0 | By Casdin Venture Opportunities Fund, L.P. | 01/01/2023 |
| 01/01/2023 | EQRx, Inc. | | Grant | Earn-out Shares | 4k | $0.00 | $0 | By Casdin Private Growth Equity Fund, L.P. | 01/01/2023 |
| 11/17/2022 | Tenaya Therapeutics, Inc. | | Purchase | Common Stock | 2.5M | $2.60 | $6.5M | See footnote | 11/17/2022 |
| 11/17/2022 | Tenaya Therapeutics, Inc. | | Purchase | Warrant | 1.4M | $0.00 | $1.4k | See footnote | 11/17/2022 |
| 09/30/2022 | EQRx, Inc. | | Grant | Stock Option (Right to Buy) | 101k | $4.95 | $500k | | 09/30/2022 |
| 09/29/2022 | SomaLogic, Inc. | | Grant | Class A Common Stock | 215.2k | $0.00 | $0 | See footnote | 09/29/2022 |
| 06/15/2022 | STANDARD BIOTOOLS INC. | FLDM | Grant | Common Stock | 30.9k | $0.00 | $0 | | 06/15/2022 |
| 06/15/2022 | STANDARD BIOTOOLS INC. | FLDM | Grant | Stock Option (Right to Buy) | 42.6k | $1.86 | $79.2k | | 06/15/2022 |
| 06/10/2022 | Tenaya Therapeutics, Inc. | | Grant | Stock Option (Right to buy) | 39.7k | $5.26 | $209k | | 06/10/2022 |
| 06/09/2022 | Century Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 19.9k | $8.56 | $170.1k | | 06/09/2022 |
| 06/08/2022 | Absci Corp | BSCI | Grant | Stock Option (right to buy) | 28.7k | $3.39 | $97.3k | | 06/08/2022 |
| 05/02/2022 | GeneDx Holdings Corp. | | Grant | Stock Option | 78.9k | $0.00 | $0 | | 05/02/2022 |
| 05/02/2022 | GeneDx Holdings Corp. | | Grant | Stock Option (Right to Buy) | 78.9k | $2.16 | $170.1k | | 05/02/2022 |
| 05/02/2022 | GeneDx Holdings Corp. | | Grant | Restricted Stock Unit | 45.5k | $0.00 | $0 | | 05/02/2022 |
| 04/29/2022 | GeneDx Holdings Corp. | | Purchase | Class A Common Stock | 11.4M | $4.00 | $45.8M | By Casdin Partners Master Fund, LP | 04/29/2022 |
| 04/27/2022 | GeneDx Holdings Corp. | | Exercise | Restricted Stock Unit | 12.8k | $0.00 | $0 | | 04/27/2022 |
| 04/04/2022 | STANDARD BIOTOOLS INC. | FLDM | Grant | Stock Option (Right to Buy) | 23.4k | $3.99 | $93.4k | | 04/04/2022 |
| 04/04/2022 | STANDARD BIOTOOLS INC. | FLDM | Grant | Series B-1 Convertible Preferred Stock | 127.8k | $0.00 | $0 | See footnote | 04/04/2022 |
| 04/04/2022 | STANDARD BIOTOOLS INC. | FLDM | Grant | Common Stock | 15.9k | $0.00 | $0 | | 04/04/2022 |
| 03/01/2022 | SomaLogic, Inc. | | Grant | Common Stock | 3.4k | $0.00 | $0 | | 03/01/2022 |
| 03/01/2022 | SomaLogic, Inc. | | Grant | Employee Stock Option (right to buy) | 20.6k | $9.08 | $187k | | 03/01/2022 |
| 12/17/2021 | EQRx, Inc. | | Other (acquisition) | Common Stock | 8.7M | $0.00 | $0 | By CMLS Holdings III LLC | 12/17/2021 |
| 12/17/2021 | EQRx, Inc. | | Grant | Common Stock | 34.5M | $0.00 | $0 | Casdin Partners Master Fund, L.P. | 12/17/2021 |
| 12/17/2021 | EQRx, Inc. | | Grant | Common Stock | 5M | $10.00 | $50M | Casdin Partners Master Fund, L.P. | 12/17/2021 |
| 12/17/2021 | EQRx, Inc. | | Other (disposition) | Class B Common Stock | 4.8M | $0.00 | $0 | By CMLS Holdings III LLC | 12/17/2021 |
| 12/17/2021 | EQRx, Inc. | | Other (disposition) | Class B Common Stock | 8.7M | $0.00 | $0 | By CMLS Holdings III LLC | 12/17/2021 |
| 12/17/2021 | EQRx, Inc. | | Grant | Warrants to purchase Class A Common Stock (right to buy) | 8.1M | $11.50 | $93.3M | By CMLS Holdings III LLC | 12/17/2021 |
|
|